Chinese expert consensus on perioperative management of renal tumor cryoablation (2022 edition).
10.3760/cma.j.cn112138-20221024-00780
- Author:
Tong Guo SI
1
;
Long LI
2
;
Zhi GUO
1
;
Bin XU
2
Author Information
1. Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
2. Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Carcinoma, Renal Cell/surgery*;
Consensus;
Cryosurgery/methods*;
Kidney Neoplasms/pathology*;
Treatment Outcome;
China
- From:
Chinese Journal of Internal Medicine
2023;62(4):363-368
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, the incidence of renal cancer has been increasing continuously. Surgical resection is the "gold standard" for the treatment of small renal cancer. However, local ablation therapy of renal cancer is undoubtedly the best choice for patients with short life expectancy, other complications, and impaired renal function who are not suitable for surgery. In recent years, with the development of ablation techniques and long-term follow-up, local ablation has shown good therapeutic effects. As many domestic hospitals are performing or planning to perform renal tumor cryoablation to improve the clinical cure rate and surgical safety of renal tumor cryoablation, it is necessary to standardize the surgical indications, contraindications, perioperative management, efficacy evaluation, and other common problems. Currently, there is no expert consensus regarding perioperative renal tumor cryoablation in China. To standardize the perioperative management of renal tumor cryoablation and related technical operations in clinical practice, and improve the effectiveness and safety of cryoablation, the expert committee of Tumor Interventional and Minimally Invasive Diagnosis and Treatment Continuing Education Base of the Chinese Anti-Cancer Association convened experts in related fields to discuss and formulate this consensus, which is hereby published, for clinical reference and application.
